Brokerages Set Teleflex Incorporated (NYSE:TFX) PT at $260.14

Teleflex Incorporated (NYSE:TFXGet Free Report) has been given an average rating of “Moderate Buy” by the eight ratings firms that are covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $262.43.

Several brokerages have recently weighed in on TFX. Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and boosted their price target for the company from $205.00 to $245.00 in a research report on Monday, July 1st. Truist Financial boosted their price target on shares of Teleflex from $219.00 to $235.00 and gave the company a “hold” rating in a research report on Tuesday. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Friday, May 3rd.

Get Our Latest Analysis on Teleflex

Teleflex Trading Up 3.0 %

Shares of TFX stock opened at $218.08 on Wednesday. The company’s 50-day moving average price is $208.44 and its 200-day moving average price is $224.07. The company has a current ratio of 2.51, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37. The stock has a market cap of $10.27 billion, a price-to-earnings ratio of 35.00, a PEG ratio of 2.05 and a beta of 1.13. Teleflex has a twelve month low of $177.63 and a twelve month high of $262.97.

Teleflex (NYSE:TFXGet Free Report) last announced its quarterly earnings results on Thursday, May 2nd. The medical technology company reported $3.21 earnings per share for the quarter, beating the consensus estimate of $3.07 by $0.14. The firm had revenue of $737.80 million for the quarter, compared to analysts’ expectations of $726.85 million. Teleflex had a net margin of 9.82% and a return on equity of 14.78%. The company’s revenue was up 3.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.09 EPS. As a group, equities analysts predict that Teleflex will post 13.75 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 14th. Shareholders of record on Wednesday, May 15th were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Tuesday, May 14th. This represents a $1.36 dividend on an annualized basis and a yield of 0.62%. Teleflex’s dividend payout ratio (DPR) is presently 21.83%.

Institutional Trading of Teleflex

Institutional investors and hedge funds have recently bought and sold shares of the business. Victory Capital Management Inc. increased its stake in Teleflex by 47.8% during the fourth quarter. Victory Capital Management Inc. now owns 21,865 shares of the medical technology company’s stock worth $5,452,000 after purchasing an additional 7,070 shares during the period. BNP Paribas Financial Markets increased its stake in Teleflex by 35.5% during the fourth quarter. BNP Paribas Financial Markets now owns 39,735 shares of the medical technology company’s stock worth $9,908,000 after purchasing an additional 10,405 shares during the period. Allspring Global Investments Holdings LLC increased its stake in Teleflex by 243.6% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 22,722 shares of the medical technology company’s stock worth $5,666,000 after purchasing an additional 16,110 shares during the period. Charles Schwab Investment Management Inc. increased its stake in Teleflex by 3.1% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 405,203 shares of the medical technology company’s stock worth $101,033,000 after purchasing an additional 12,150 shares during the period. Finally, Massachusetts Financial Services Co. MA increased its stake in Teleflex by 9.0% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 432,939 shares of the medical technology company’s stock worth $107,949,000 after purchasing an additional 35,847 shares during the period. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Company Profile

(Get Free Report

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Featured Articles

Analyst Recommendations for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.